Cardiovascular Disease Predicts Structural and Functional Progression in Early Glaucoma.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
01 2021
Historique:
received: 11 05 2020
revised: 24 06 2020
accepted: 30 06 2020
pubmed: 31 7 2020
medline: 13 4 2021
entrez: 31 7 2020
Statut: ppublish

Résumé

To investigate the association between cardiovascular disease and baseline structural defects and disease progression in glaucoma. Prospective, longitudinal study of preperimetric and perimetric glaucoma. Two thousand six hundred twenty-eight eyes from 1314 participants recruited to the Progression Risk of Glaucoma: Relevant SNPs with Significant Association (PROGRESSA) study were evaluated for baseline and longitudinal structural thinning using spectral-domain OCT and for visual field progression on Humphrey visual field (HVF) assessment. Patients were classified as either predominantly macula ganglion cell-inner plexiform layer (mGCIPL), predominantly peripapillary retinal nerve fiber layer (pRNFL), or both mGCIPL and pRNFL structural change at enrollment, and then evaluated for longitudinal OCT or HVF progression. Cardiovascular disease and medication characteristics of the participants were compared with a reference group of stable patients. OCT and HVF baseline status and longitudinal progression. After accounting for age and cardiovascular characteristics, patients with predominantly mGCIPL thinning at baseline showed a higher prevalence of hypertension (odds ratio [OR], 2.70; 95% confidence interval [CI], 1.66-4.41; P < 0.001), antihypertensive use (OR, 2.03; 95% CI, 1.20-3.46; P = 0.008), and statin use (OR, 1.98; 95% CI, 1.07-3.66; P = 0.029) than reference patients. Patients with predominantly pRNFL thinning exhibited a comparable prevalence of cardiovascular disease or medication with reference patients. Review of longitudinal OCT and HVF data (mean follow-up, 5.34 ± 1.29 years) showed that hypertension was associated with an increased risk of both OCT (OR, 1.79; 95% CI, 1.17-2.75; P = 0.006) and HVF progression (OR, 1.92; 95% CI, 1.18-3.15; P = 0.013). A 1-standard deviation (approximately 21 mmHg) increase in systolic blood pressure at baseline was associated with a greater risk of OCT progression (OR, 1.27; 95% CI, 1.01-1.63; P = 0.041) and HVF progression (OR, 1.32; 95% CI, 1.01-1.73; P = 0.043). The association between systolic blood pressure and structural progression was comparable to that observed between intraocular pressure and structural progression (OR, 1.30; 95% CI, 1.01-1.67; P = 0.039). Cardiovascular disease is an important risk factor for glaucoma progression.

Identifiants

pubmed: 32730956
pii: S0161-6420(20)30706-5
doi: 10.1016/j.ophtha.2020.06.067
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-69

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Auteurs

Henry Marshall (H)

Department of Ophthalmology, Flinders University, Adelaide, Australia. Electronic address: h.n.marshall@outlook.com.

Sean Mullany (S)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Ayub Qassim (A)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Owen Siggs (O)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Mark Hassall (M)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Bronwyn Ridge (B)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Thi Nguyen (T)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Mona Awadalla (M)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Nicholas H Andrew (NH)

Discipline of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, South Australia.

Paul R Healey (PR)

Centre for Vision Research, University of Sydney, Sydney, Australia.

Ashish Agar (A)

Department of Ophthalmology, University of New South Wales, Sydney, Australia.

Anna Galanopoulos (A)

Discipline of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, South Australia.

Alex W Hewitt (AW)

Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.

Stuart MacGregor (S)

QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Stuart L Graham (SL)

Faculty of Health and Medical Sciences, Macquarie University, Sydney, Australia.

Richard Mills (R)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Angela Shulz (A)

Faculty of Health and Medical Sciences, Macquarie University, Sydney, Australia.

John Landers (J)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Robert J Casson (RJ)

Discipline of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, South Australia.

Jamie E Craig (JE)

Department of Ophthalmology, Flinders University, Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH